JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells

Inhibition of Glycogen Synthase Kinase-3 in Androgen-Responsive Prostate Cancer Cell Lines: Are GSK Inhibitors Therapeutically Useful?

(2015) Ludwig Rinnab et al.   NEOPLASIA

Alternatively spliced androgen receptor variants

(2011) Scott M Dehm et al.   ENDOCRINE-RELATED CANCER

Characterising the castration-resistant prostate cancer population: a systematic review

(2011) M. Kirby et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Inhibition of Glycogen Synthase Kinase-3β Counteracts Ligand-Independent Activity of the Androgen Receptor in Castration Resistant Prostate Cancer

(2011) Stefanie V. Schütz et al.   PLoS One

JS-K; a nitric oxide-releasing prodrug, modulates β-catenin/TCF signaling in leukemic Jurkat cells: Evidence of an S-nitrosylated mechanism

(2010) Niharika Nath et al.   BIOCHEMICAL PHARMACOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

JS-K has potent anti-angiogenic activityin vitroand inhibits tumour angiogenesis in a multiple myeloma modelin vivo

(2010) Tanyel Kiziltepe et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Nitric Oxide Inhibits the Proliferation and Invasion of Pancreatic Cancer Cells through Degradation of Insulin Receptor Substrate-1 Protein

(2010) H. Sugita et al.   MOLECULAR CANCER RESEARCH

Nitric Oxide-Releasing Silica Nanoparticle Inhibition of Ovarian Cancer Cell Growth

(2010) Ellen V. Stevens et al.   MOLECULAR PHARMACEUTICS

Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols

(2010) Piwen Wang et al.   PLoS One

Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor

(2010) P. A. Watson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nitro-aspirin inhibits MCF-7 breast cancer cell growth: Effects on COX-2 expression and Wnt/β-catenin/TCF-4 signaling

(2009) Niharika Nath et al.   BIOCHEMICAL PHARMACOLOGY

Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders

(2009) Jagat Kanwar et al.   CURRENT MEDICINAL CHEMISTRY

Biochemical and cellular toxicology of peroxynitrite: implications in cell death and autoimmune phenomenon

(2009) Rizwan Ahmad et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Phase II Study of Nitric Oxide Donor for Men With Increasing Prostate-specific Antigen Level After Surgery or Radiotherapy for Prostate Cancer

(2009) D. Robert Siemens et al.   UROLOGY

Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance

(2008) S. M. Dehm et al.   CANCER RESEARCH

Crosstalk between the Androgen Receptor and  -Catenin in Castrate-Resistant Prostate Cancer

(2008) G. Wang et al.   CANCER RESEARCH